Berkeley, Inc Abb Vie Inc. Transaction History

Berkeley, Inc

$213 Billion
Q1 2025

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 04, 2025	SELL	$138.31 - $165.87 $1.04 Million - $1.24 Million	-7,501 Closed	0 $0
Q3 2022 Mar 28, 2025	BUY	$134.21 - $153.93 $6,039 - $6,926	45 Added 0.6%	7,501 $1.01 Billion
Q3 2022 Mar 04, 2025	BUY	$134.21 - $153.93 $6,039 - $6,926	45 Added 0.6%	7,501 $1.01 Billion
Q2 2022 Mar 28, 2025	SELL	$137.62 - $174.96 $23,945 - $30,443	-174 Reduced 2.28%	7,456 $1.14 Billion
Q2 2022 Mar 04, 2025	SELL	$137.62 - $174.96 $23,945 - $30,443	-174 Reduced 2.28%	7,456 $1.14 Billion
Q1 2022 Mar 28, 2025	SELL	$131.98 - $163.75 $2.26 Million - $2.81 Million	-17,158 Reduced 69.22%	7,630 $1.24 Billion
Q1 2022 Mar 04, 2025	SELL	$131.98 - $163.75 $2.26 Million - $2.81 Million	-17,158 Reduced 69.22%	7,630 $1.24 Billion
Q4 2021 Mar 28, 2025	BUY	$107.43 - $135.93 $28,898 - $36,565	269 Added 1.1%	24,788 $3.36 Billion
Q4 2021 Mar 04, 2025	BUY	$107.43 - $135.93 $28,898 - $36,565	269 Added 1.1%	24,788 $3.36 Billion
Q3 2021 Mar 28, 2025	SELL	$106.4 - $120.78 $22,344 - $25,363	-210 Reduced 0.85%	24,519 $2.64 Billion
Q3 2021 Mar 04, 2025	SELL	$106.4 - $120.78 $22,344 - $25,363	-210 Reduced 0.85%	24,519 $2.64 Billion
Q2 2021 Mar 28, 2025	BUY	$105.21 - $117.21 $49,553 - $55,205	471 Added 1.94%	24,729 $2.79 Billion
Q2 2021 Mar 04, 2025	BUY	$105.21 - $117.21 $49,553 - $55,205	471 Added 1.94%	24,729 $2.79 Billion
Q1 2021 Mar 28, 2025	BUY	$102.3 - $112.62 $2.48 Million - $2.73 Million	24,258 New	24,258 $2.63 Billion
Q1 2021 Mar 04, 2025	BUY	$102.3 - $112.62 $446,437 - $491,473	4,364 Added 21.94%	24,258 $2.63 Billion
Q4 2020 Mar 28, 2025	BUY	$80.49 - $108.67 $1.6 Million - $2.16 Million	19,894 New	19,894 $2.13 Billion
Q4 2020 Feb 28, 2025	BUY	$80.49 - $108.67 $1.6 Million - $2.16 Million	19,894 New	19,894 $2.13 Billion

Others Institutions Holding ABBV

# of Institutions

4,264

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $329B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley, Inc with notifications on news.

Account